Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus

Clinical Infectious Diseases

Volumn 23, Issue 6, 1996, Pages 1255-1260

  Van Elsacker Niele, A M W ^a   Kroon, F P ^b   Van Der Ende, M E ^b   Salimans, M M M ^b   Spaan, W J M ^b   Kroes, A C M ^b  

^a Public Health Service of Northern Friesland   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DIAGNOSIS;

EID: 0030462814     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.6.1255     Document Type: Article

References (17)

1. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994; 16:1-31.
2. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988; 25:159-72.
3. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84:1114-23.
4. Frickhofen N, Young NS. Persistent parvovirus B19 infections in humans. Microb Pathog 1989; 7:319-27.
5. Spivak JL, Bender BS, Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984; 77:224-8.
6. Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 1988; 25:208-18.
7. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113:926-32.
8. Mitchell SA, Welch JM, Weston-Smith S, Nicholson F, Bradbeer CS. Parvovirus infection and anaemia in a patient with AIDS: case report. Genitourin Med 1990; 66:95-6.
9. Bowman CA, Cohen BJ, Norfolk DR, Lacey CJN. Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin. AIDS 1990; 4:1038-9.
10. Griffin TC, Squires JE, Timmons CF, Buchanan GR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991; 118: 899-901.
11. Gottlieb F, Deutsch J. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection. Am J Med 1992; 92:331-3.
12. Bremner JAG, Beard S, Cohen BJ, Alimenti A, Cantiniaux B, Levy J. Secondary infection with parvovirus B19 in an HIV-positive patient [letter]. AIDS 1993; 7:1131-2.
13. Blanche P, Wyplosz B, Herry I, Salmon D, Sicard D. Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a woman seropositive for human immunodeficiency virus [letter]. Clin Infect Dis 1994; 19:215.
14. Zuckerman MA, Williams I, Bremner J, Cohen B, Miller RF. Persistent anaemia in HIV-infected individuals due to parvovirus B19 infection [letter]. AIDS 1994; 8:1191-2.
15. Musiani M, Zerbini M, Gentilomi G, et al. Persistent B19 parvovirus infection in haemophilic HIV-1 infected patients. J Med Virol 1995; 46:103-8.
16. Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993; 168: 101-5.
17. Bremner JAG, Cohen BJ. Parvovirus B19 as a cause of anemia in human immunodeficiency virus-infected patients [letter]. J Infect Dis 1994; 169:938-9.